Diabetes 55 , 341348 (2006)
academic medical clinics, finding that most patients had kept the weight off or lost even more weight 18 months after stopping semaglutide, sold as Ozempic and Wegovy, or tirzepatide, sold as Mounjaro and Zepbound
Ozempic, an earlier formulation of semaglutide, was approved by the FDA in 2017 for use in patients with diabetes because it lowers blood glucose
p 1 year) is sparse
The beneficial effectswere mediated through the GLP-1R/SIRT1/GLUT4 pathway, which regulates glucose uptake and utilization in the brain, as well as influencing neuroprotective processes (125)
The North Carolina State Health Plan provides a striking example of the financial implications involved, estimating that continuing to cover brand GLP-1s for weight loss in 2024 would require increasing premiums by $48.50 per subscriber per month for all members, not just GLP-1 users